High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells.

导出原文传递

翻译打印收藏纠错

第一作者： Thomas,Horn

第一单位： Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.

作者： Thomas,Horn ^[1] ; Stéphane,Ferretti ^[2] ; Nicolas,Ebel ^[2] ; Angela,Tam ^[1] ; Samuel,Ho ^[3] ; Fred,Harbinski ^[4] ; Ali,Farsidjani ^[3] ; Matthew,Zubrowski ^[1] ; William R,Sellers ^[3] ; Robert,Schlegel ^[1] ; Dale,Porter ^[1] ; Erick,Morris ^[1] ; Jens,Wuerthner ^[2] ; Sébastien,Jeay ^[2] ; Joel,Greshock ^[1] ; Ensar,Halilovic ^[1] ; Levi A,Garraway ^[5] ; Giordano,Caponigro ^[6] ; Joseph,Lehár ^[6]

作者单位： Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. ^[1] Oncology Disease Area, Novartis Institutes for Biomedical Research, Basel, Switzerland. ^[2] Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. ^[3] Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. ^[4] Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts. ^[5] Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. giordano.caponigro@novartis.com lehar@google.com. ^[6]